Hypofractionated Radiotherapy for Soft Tissue Sarcomas
Condition(s):Soft Tissue SarcomaLast Updated:January 24, 2024Active, not recruiting
Hide Studies Not Open or Pending
Condition(s):Soft Tissue SarcomaLast Updated:January 24, 2024Active, not recruiting
Condition(s):NK Cell Mediated Immunity; NK Cell Cytokine Production; Kidney CancerLast Updated:September 21, 2021Completed
Condition(s):Esophageal TumorsLast Updated:November 18, 2023Recruiting
Condition(s):Cancer of Endometrium Stage I; Cancer of Endometrium Stage IILast Updated:May 10, 2023Recruiting
Condition(s):Esophageal CancerLast Updated:December 21, 2012Completed
Condition(s):RhabdomyosarcomaLast Updated:February 9, 2024Active, not recruiting
Condition(s):B-Cell Lymphoma; Large B-cell Lymphoma; DLBCL, Nos Genetic Subtypes; High-grade B Cell Lymphoma; Mediastinal Large B-cell LymphomaLast Updated:February 29, 2024Recruiting
Condition(s):Ovarian CancerLast Updated:March 3, 2009Unknown status
Condition(s):Patient Satisfaction; Bladder CancerLast Updated:October 30, 2020Unknown status
Condition(s):Breast CancerLast Updated:August 8, 2023Not yet recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.